Concurrent inhibition of NF-κB, cyclooxy
✍
Shadan Ali; Sanjeev Banerjee; Jacqueline M. Schaffert; Bassel F. El-Rayes; Phili
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 659 KB
## Abstract Inactivation of survival pathways such as NF‐κB, cyclooxygenase (COX‐2), or epidermal growth factor receptor (EGFR) signaling individually may not be sufficient for the treatment of advanced pancreatic cancer (PC) as suggested by recent clinical trials. 3,3′‐Diindolylmethane (B‐DIM) is